Skip to main content

Advertisement

Log in

Clinical efficiency of Helicobacter pylori eradication in the treatment of patients with acute central serous chorioretinopathy

  • Retinal Disorders
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Background

Although the majority of cases of acute central serous chorioretinopathy are self-limited, resolving spontaneously after a number of weeks, the recurrence rate is estimated to be 20–50 %, and some cases will be chronic, lasting 6 months or longer. The evidence of Helicobacter pylori infection appears more often in patients with central serous chorioretinopathy. The purpose of this work was to estimate the efficiency of H. pylori infection eradication in treatment of patients with acute central serous chorioretinopathy.

Methods

Ninety-three patients with acute central serous chorioretinopathy participated in this study. Patients were divided into an experimental group (33 Helicobacter pylori-positive patients who received eradication treatment) and two control groups who did not receive eradication treatment: 29 H. pylori-positive patients and 31 H. pylori-negative patients. Research methods were best-corrected Snellen visual acuity, optical coherence tomography, fluorescein angiography. Research methods were best-corrected Snellen visual acuity, optical coherence tomography, static perimetry, and Amsler grid. The follow-up period was 2 years.

Results

Helicobacter pylori eradication caused a decrease of disease duration at 3 months (p = 0.04) and recurrence frequency of 45.6 % (p = 0.03) as well as improvement of distant prognosis. After 2 years, visual acuity increased from 0.91 ± 0.07 to 0.99 ± 0.02 (p = 0.01), scotoma frequency decreased from 100 % eyes to 27.2 % (p = 0.001), and metamorphopsia frequency decreased from 57.6 % eyes to 39.4 % (p = 0.04).

Conclusions

Helicobacter pylori eradication is effective in the treatment of H. pylori-positive patients with acute central serous chorioretinopathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Spaide RF, Campeas L, Haas A, Yannuzzi LA, Fisher YL, Guyer DR, Slakter JS, Sorenson JA, Orlock DA (1996) Central serous chorioretinopathy in younger and older adults. Ophthalmology 103:2070–2079, discussion 2079–2080

    Article  CAS  PubMed  Google Scholar 

  2. Otsuka S, Ohba N, Nakao K (2002) A long-term follow-up study of severe variant of central serous chorioretinopathy. Retina 22:25–32

    Article  PubMed  Google Scholar 

  3. Kitzmann AS, Pulido JS, Diehl NN, Hodge DO, Burke JP (2008) The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980–2002. Ophthalmology 115(1):169–73. doi:10.1016/j.ophtha.2007.02.032

    Article  PubMed  Google Scholar 

  4. Fok AC, Chan PP, Lam DS, Lai TY (2011) Risk factors for recurrence of serous macular detachment in untreated patients with central serous chorioretinopathy. Ophthalmic Res 46(3):160–3. doi:10.1159/000324599

    Article  PubMed  Google Scholar 

  5. Piccolino FC, de la Longrais RR, Ravera G, Eandi CM, Ventre L, Abdollahi A, Manea M (2005) The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. Am J Ophthalmol 139(1):87–99

    Article  PubMed  Google Scholar 

  6. Wang M, Munch IM, Hasler PW, Prünte C, Larsen M (2008) Central serous chorioretinopathy. Acta Ophthalmol 86:126–145. doi:10.1111/j.1600-0420.2007.00889.x

    Article  PubMed  Google Scholar 

  7. Kim SW, Oh J, Huh K (2012) Correlations among various functional and morphological tests in resolved central serous chorioretinopathy. Br J Ophthalmol 96(3):350–5. doi:10.1136/bjo.2011.204503

    Article  PubMed  Google Scholar 

  8. Kitaya N, Nagaoka T, Hikichi T, Sugawara R, Fukui K, Ishiko S, Yoshida A (2003) Features of abnormal choroidal circulation in central serous chorioretinopathy. Br J Ophthalmol 87(6):709–12

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Manolakis A, Kapsoritakis AN, Potamianos SP (2007) A review of the postulated mechanisms concerning the association of Helicobacter pylori with ischemic heart. Helicobacter 12(4):287–97

    Article  PubMed  Google Scholar 

  10. Franceschi F, Roccarina D, Gasbarrini A (2006) Extragastric manifestations of Helicobacter pylori infection. Minerva Med 97(1):39–45

    CAS  PubMed  Google Scholar 

  11. Franceschi F, Navarese EP, Mollo R, Giupponi B, De Marco G, Merra G, Gasbarrini G, Silveri NG (2009) Helicobacter pylori and atherosclerosis. A review of the literature. Article in Italian. Recenti Prog Med 100(2):91–6

    PubMed  Google Scholar 

  12. Franceschi F, Niccoli G, Ferrante G, Gasbarrini A, Baldi A, Candelli M, Feroce F, Saulnier N, Conte M, Roccarina D, Lanza GA, Gasbarrini G, Gentiloni SN, Crea F (2009) CagA antigen of Helicobacter pylori and coronary instability: insight from a clinico-pathological study and a meta-analysis of 4241 cases. Atherosclerosis 202(2):535–42. doi:10.1016/j.atherosclerosis.2008.04.051

    Article  CAS  PubMed  Google Scholar 

  13. De Bastiani R, Gabrielli M, Ubaldi E, Benedetto E, Sanna G, Cottone C, Candelli M, Zocco MA, Saulnier N, Santoliquido A, Papaleo P, Gasbarrini G, Gasbarrini A (2008) High prevalence of Cag-A-positive H. pylori strains in ischemic stroke: a primary care multicenter study. Helicobacter 13(4):274–7. doi:10.1111/j.1523-5378.2008.00610.x

    Article  PubMed  Google Scholar 

  14. Georges JL, Rupprecht HJ, Blankenberg S, Poirier O, Bickel C, Hafner G, Nicaud V, Meyer J, Cambien F, Tiret L, AtheroGene Group (2003) Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines. Am J Cardiol 92(5):515–21

    Article  CAS  PubMed  Google Scholar 

  15. Giusti C, Mauget-Faÿsse M (2004) Helicobacter pylori and idiopathic central serous chorioretinopathy. Swiss Med Wkly 134(27–28):395–8

    PubMed  Google Scholar 

  16. Whittle BJ, Morschl E, Pozsár J, Moran AP, László F (2001) Helicobacter pylori lipopolysaccharide provokes iNOS-mediated acute systemic microvascular inflammatory responses in rat cardiac, hepatic, renal and pulmonary tissues. J Physiol Paris 95(1–6):257–9

    Article  CAS  PubMed  Google Scholar 

  17. Giusti C (2004) Association of Helicobacter pylori with central serous chorioretinopathy: hypotheses regarding pathogenesis. Med Hypotheses 63(3):524–7

    Article  PubMed  Google Scholar 

  18. Giusti C (2001) Central serous chorioretinopathy: a new extragastric manifestation of Helicobacter pylori?: Analysis of a clinical case. Article in Italian. Clin Ter 152(6):393–7

    CAS  PubMed  Google Scholar 

  19. Mauget-Faÿsse M, Kodjikian L, Quaranta M, Ben Ezra D, Trepsat C, Mion F, Mégraud F (2002) Helicobacter pylori in central serous chorioretinopathy and diffuse retinal epitheliopathy. Results of the first prospective pilot study. Article in French. J Fr 25(10):1021–1025

    Google Scholar 

  20. Ahnoux-Zabsonre A, Quaranta M, Mauget-Faysse M (2004) Pre’valence de l’Helicobacter pylori dans la choriore’tinopathie se’reuse centrale et l’e’pithe’liopathie re’tinienne diffuse. J Fr Ophtalmol 27:1129–1133

    Article  CAS  PubMed  Google Scholar 

  21. Asensio-Sánchez VM, Rodríguez-Delgado B, García-Herrero E, Cabo-Vaquera V, García-Loygorri C (2008) Central serous chorioretinopathy as an extradigestive manifestation of Helicobacter pylori gastric infection. Article in Spanish. Arch Soc Esp Oftalmol 83:177–182

    PubMed  Google Scholar 

  22. Cotticelli L, Borrelli M, D'Alessio AC, Menzione M, Villani A, Piccolo G, Montella F, Iovene MR, Romano M (2006) Central serous chorioretinopathy and Helicobacter pylori. Eur J Ophthalmol 16(2):274–8

    CAS  PubMed  Google Scholar 

  23. Misiuk-Hojło M, Michałowska M, Zołyńska M (2007) Helicobacter pylori-a risk factor for the development of the central serous chorioretinopathy. Klin Oczna 109(10–12):479–481

    PubMed  Google Scholar 

  24. Abreu R, Nadal J, Abreu P (2008) Helicobacter pylori and central serous chorioretinopathy. Arch Soc Esp Oftalmol 83(11):637–8

    Article  CAS  PubMed  Google Scholar 

  25. Rahbani-Nobar MB, Javadzadeh A, Ghojazadeh L, Rafeey M, Ghorbanihaghjo A (2011) The effect of Helicobacter pylori treatment on remission of idiopathic central serous chorioretinopathy. Mol Vis 17:99–103

    PubMed  PubMed Central  Google Scholar 

  26. Casella AMB, Berbel RF, Bressanim GL, Malaguido MR, Cardillo JA (2012) Helicobacter pylori as a potential target for the treatment of central serous chorioretinopathy. Clinics (Sao Paulo) 67(9):1047–1052. doi:10.6061/clinics/2012(09)11

    Article  Google Scholar 

  27. Dang Y, Mu Y, Zhao M, Li L, Guo Y, Zhu Y (2013) The effect of eradicating Helicobacter pylori on idiopathic central serous chorioretinopathy patients. Ther Clin Risk Manag 9:355–60

    Article  PubMed  PubMed Central  Google Scholar 

  28. Gatta L, Ricci C, Tampieri A, Osborn J, Perna F, Bernabucci V, Vaira D (2005) Accuracy of breath tests using low doses of 13C-urea to diagnose Helicobacter pylori infection: a randomised controlled trial. Gut 55:457–462. doi:10.1136/gut.2005.078626

    Article  PubMed  Google Scholar 

  29. Calvet X, Sánchez-Delgado J, Montserrat A, Lario S, Ramírez-Lázaro MJ, Quesada M, Casalots A, Suárez D, Campo R, Brullet E, Junquera F, Sanfeliu I, Segura F (2009) Accuracy of diagnostic tests for Helicobacter pylori: a reappraisal. Clin Infect Dis 48:1385–91. doi:10.1086/598198

    Article  PubMed  Google Scholar 

  30. Al-Humayed SM, Ahmed ME, Bello CS, Tayyar MA (2008) Comparison of 4 laboratory methods for detection of Helicobacter pylori. Saudi Med J 29:530–2

    PubMed  Google Scholar 

  31. Redéen S, Petersson F, Törnkrantz E, Levander H, Mårdh E, Borch K (2011) Reliability of diagnostic tests for Helicobacter pylori infection. Gastroenterol Res Pract 2011:940650. doi:10.1155/2011/940650

    Article  PubMed  PubMed Central  Google Scholar 

  32. Mégraud F, Bessède E, Lehours P (2014) Current methods used for the diagnosis of Helicobacter pylori infection. In: Buzás GM (ed) Helicobacter pylori - A Worldwide Perspective 2014. Bentham Science, Oak Park, pp 234–58

    Chapter  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Olesya Zavoloka.

Ethics declarations

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Conflict of interest

The author(s) declare that they have no competing interests.

Financial disclosures

The authors have no financial interest in any of the materials used in this study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zavoloka, O., Bezditko, P., Lahorzhevska, I. et al. Clinical efficiency of Helicobacter pylori eradication in the treatment of patients with acute central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 254, 1737–1742 (2016). https://doi.org/10.1007/s00417-016-3315-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-016-3315-0

Keywords

Navigation